{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T23:54:23Z","timestamp":1784850863148,"version":"3.55.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.ccm.2013.02.003","type":"journal-article","created":{"date-parts":[[2013,4,9]],"date-time":"2013-04-09T03:51:08Z","timestamp":1365479468000},"page":"217-228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Human Immunodeficiency Virus\u2013Associated Tuberculosis"],"prefix":"10.1016","volume":"34","author":[{"given":"Kerry L.","family":"Dierberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Chaisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9785","key":"10.1016\/j.ccm.2013.02.003_bib1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(10)62173-3","article-title":"Tuberculosis","volume":"378","author":"Lawn","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ccm.2013.02.003_bib2","unstructured":"WHO global tuberculosis report. 2012. Available at: http:\/\/www.who.int\/tb\/publications\/global_report\/en\/. Accessed December 29, 2012."},{"issue":"4","key":"10.1016\/j.ccm.2013.02.003_bib3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.167.4.603","article-title":"American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America: treatment of tuberculosis","volume":"167","author":"Blumberg","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"RR-4","key":"10.1016\/j.ccm.2013.02.003_bib4","first-page":"1","article-title":"Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America","volume":"58","author":"Kaplan","year":"2009","journal-title":"MMWR Recomm Rep"},{"issue":"7","key":"10.1016\/j.ccm.2013.02.003_bib5","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1086\/656282","article-title":"Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa","volume":"51","author":"Bassett","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"22","key":"10.1016\/j.ccm.2013.02.003_bib6","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1001\/jama.293.22.2740","article-title":"Clinical and radiographic correlates of primary and reactivation tuberculosis: a molecular epidemiology study","volume":"293","author":"Geng","year":"2005","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.ccm.2013.02.003_bib7","first-page":"1295","article-title":"Significant variation in presentation of pulmonary tuberculosis across a high resolution of CD4 strata","volume":"14","author":"Chamie","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ccm.2013.02.003_bib8","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1093\/infdis\/jis009","article-title":"Prevention, diagnosis, and treatment of tuberculosis in children and mothers: evidence for action for maternal, neonatal, and child health services","volume":"205","author":"Getahun","year":"2012","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.ccm.2013.02.003_bib9","first-page":"181","article-title":"Trends in tuberculosis\u2014United States, 2011","volume":"61","author":"Centers for Disease Control and Prevention (CDC)","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ccm.2013.02.003_bib10","unstructured":"Fujiwara PI, Dlodlo RA, Ferroussier O, et\u00a0al. Implementing collaborative TB-HIV activities: a programmatic guide. 2012. Available at: http:\/\/www.theunion.org\/index.php\/en\/resources\/technical-publications\/item\/2091-implementing-collaborative-tb-hiv-activities-a-programmatic-guide. Updated 2012."},{"key":"10.1016\/j.ccm.2013.02.003_bib11","unstructured":"WHO Treatment of tuberculosis: Guidelines for national programmes. 2012. Available at: http:\/\/www.who.int\/tb\/publications\/tb_treatmentguidelines\/en\/index.html. Accessed December 29, 2012."},{"key":"10.1016\/j.ccm.2013.02.003_bib12","unstructured":"WHO WHO three 'I's meeting: Intensified case finding, isoniazid preventive therapy and TB infection control for people living with HIV. 2012. Available at: http:\/\/www.who.int\/hiv\/pub\/tb\/3is_mreport\/en\/index.html. Accessed December 29, 2012."},{"issue":"1","key":"10.1016\/j.ccm.2013.02.003_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000391","article-title":"Development of a standardized screening rule for tuberculosis in people living with HIV in resource constrained settings: individual patient data meta-analysis","volume":"8","author":"Getahun","year":"2011","journal-title":"PLoS Med"},{"issue":"10","key":"10.1016\/j.ccm.2013.02.003_bib14","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/cid\/cir605","article-title":"Symptom screening among HIV-infected pregnant women is acceptable and has high negative predictive value for active tuberculosis","volume":"53","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"9776","key":"10.1016\/j.ccm.2013.02.003_bib15","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(11)60438-8","article-title":"Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB\/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study","volume":"377","author":"Boehme","year":"2011","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ccm.2013.02.003_bib16","doi-asserted-by":"crossref","first-page":"e1001067","DOI":"10.1371\/journal.pmed.1001067","article-title":"Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB\/RIF assay: a prospective study","volume":"8","author":"Lawn","year":"2011","journal-title":"PLoS Med"},{"issue":"S3","key":"10.1016\/j.ccm.2013.02.003_bib17","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1086\/651488","article-title":"New diagnostic tests for tuberculosis: Bench, bedside, and beyond","volume":"50","author":"Dorman","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.ccm.2013.02.003_bib18","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1371\/journal.pmed.0050156","article-title":"Evidence-based tuberculosis diagnosis","volume":"5","author":"Pai","year":"2008","journal-title":"PLoS Medicine"},{"issue":"7","key":"10.1016\/j.ccm.2013.02.003_bib19","first-page":"408","article-title":"Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings","volume":"9","author":"Reid","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ccm.2013.02.003_bib20","unstructured":"World Health Organization. Use of tuberculosis interferon-gamma release assays (IGRAs) in low and middle-income countries: policy statement. Available at: http:\/\/www.who.int\/tb\/features_archive\/policy_statement_igra_oct2011.pdf. Accessed January 1, 2013."},{"issue":"1","key":"10.1016\/j.ccm.2013.02.003_bib21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1473-3099(11)70210-9","article-title":"Predictive value of interferon-gamma release assays for incident active tuberculosis: a systematic review and meta-analysis","volume":"12","author":"Rangaka","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.ccm.2013.02.003_bib22","first-page":"174","article-title":"Concordance of a positive tuberculin skin test and an interferon gamma release assay in bacille Calmette-Guerin vaccinated persons","volume":"15","author":"Mahan","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"10.1016\/j.ccm.2013.02.003_bib23","article-title":"Treatment of latent tuberculosis infection in HIV infected persons","author":"Akolo","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ccm.2013.02.003_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1005136","article-title":"New regimens to prevent tuberculosis in adults with HIV infection","volume":"365","author":"Martinson","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"9777","key":"10.1016\/j.ccm.2013.02.003_bib25","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/S0140-6736(11)60204-3","article-title":"6-Month versus 36-month isoniazid preventive treatment of tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial","volume":"377","author":"Samandari","year":"2011","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ccm.2013.02.003_bib26","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1093\/cid\/cis732","article-title":"Tuberculosis in pregnant and postpartum women: epidemiology, management, and research gaps","volume":"55","author":"Mathad","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"RR-6","key":"10.1016\/j.ccm.2013.02.003_bib27","first-page":"1","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society","volume":"49","year":"2000","journal-title":"MMWR Recomm Rep"},{"issue":"23","key":"10.1016\/j.ccm.2013.02.003_bib28","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ccm.2013.02.003_bib29","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"Prevention of HIV-1 infection with early antiretroviral therapy","volume":"365","author":"Cohen","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ccm.2013.02.003_bib30","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/QAD.0b013e328327964f","article-title":"Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort","volume":"23","author":"Golub","year":"2009","journal-title":"AIDS"},{"issue":"7","key":"10.1016\/j.ccm.2013.02.003_bib31","doi-asserted-by":"crossref","first-page":"e1001270","DOI":"10.1371\/journal.pmed.1001270","article-title":"Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis","volume":"9","author":"Suthar","year":"2012","journal-title":"PLoS Med"},{"issue":"12","key":"10.1016\/j.ccm.2013.02.003_bib32","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1093\/cid\/cis775","article-title":"Randomized controlled trial of isoniazid preventive therapy in HIV-infected persons on antiretroviral therapy","volume":"55","author":"Rangaka","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ccm.2013.02.003_bib33","first-page":"397","article-title":"Normal chest radiography in pulmonary tuberculosis: implications for obtaining respiratory specimen cultures","volume":"12","author":"Pepper","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"issue":"9578","key":"10.1016\/j.ccm.2013.02.003_bib34","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/S0140-6736(07)60284-0","article-title":"Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes","volume":"369","author":"Getahun","year":"2007","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ccm.2013.02.003_bib35","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1086\/595985","article-title":"Unmasked tuberculosis and tuberculosis immune reconstitution inflammatory disease: a disease spectrum after initiation of antiretroviral therapy","volume":"199","author":"Manabe","year":"2009","journal-title":"J\u00a0Infect Dis"},{"issue":"7","key":"10.1016\/j.ccm.2013.02.003_bib36","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1164\/rccm.200709-1311PP","article-title":"Immune reconstitution and \u201cunmasking\u201d of tuberculosis during antiretroviral therapy","volume":"177","author":"Lawn","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.ccm.2013.02.003_bib37","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S1473-3099(08)70184-1","article-title":"Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings","volume":"8","author":"Meintjes","year":"2008","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.ccm.2013.02.003_bib38","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1164\/ajrccm\/136.3.570","article-title":"Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival","volume":"136","author":"Chaisson","year":"1987","journal-title":"Am Rev Respir Dis"},{"issue":"12","key":"10.1016\/j.ccm.2013.02.003_bib39","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJM199503233321204","article-title":"Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months","volume":"332","author":"Perriens","year":"1995","journal-title":"N\u00a0Engl J Med"},{"issue":"9240","key":"10.1016\/j.ccm.2013.02.003_bib40","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/S0140-6736(00)02870-1","article-title":"Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial","volume":"356","author":"Fitzgerald","year":"2000","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ccm.2013.02.003_bib41","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1164\/rccm.200509-1529OC","article-title":"Treatment outcomes of patients with HIV and tuberculosis","volume":"175","author":"Nahid","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"14","key":"10.1016\/j.ccm.2013.02.003_bib42","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1097\/00002030-200309260-00007","article-title":"Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy?","volume":"17","author":"Churchyard","year":"2003","journal-title":"AIDS"},{"issue":"18","key":"10.1016\/j.ccm.2013.02.003_bib43","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1097\/QAD.0b013e328311ac4e","article-title":"Recurrent tuberculosis in HIV-infected patients in Rio de Janeiro, Brazil","volume":"22","author":"Golub","year":"2008","journal-title":"AIDS"},{"issue":"10","key":"10.1016\/j.ccm.2013.02.003_bib44","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1164\/rccm.200605-637OC","article-title":"Dosing schedules of 6-month regimens and relapse for pulmonary tuberculosis","volume":"174","author":"Chang","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccm.2013.02.003_bib45","first-page":"6","article-title":"Providing HIV care for co-infected tuberculosis patients: a perspective from Sub-Saharan Africa","volume":"13","author":"Harries","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"issue":"7","key":"10.1016\/j.ccm.2013.02.003_bib46","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2165\/00002018-200124070-00006","article-title":"Drug treatment for tuberculosis during pregnancy: safety considerations","volume":"24","author":"Bothamley","year":"2001","journal-title":"Drug Saf"},{"issue":"4","key":"10.1016\/j.ccm.2013.02.003_bib47","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1086\/338641","article-title":"Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy","volume":"34","author":"Santoro-Lopes","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.ccm.2013.02.003_bib48","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1086\/498315","article-title":"Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America","volume":"41","author":"Girardi","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.ccm.2013.02.003_bib49","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.aids.0000238406.93249.cd","article-title":"Burden of tuberculosis in an antiretroviral treatment programme in Sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control","volume":"20","author":"Lawn","year":"2006","journal-title":"AIDS"},{"issue":"18","key":"10.1016\/j.ccm.2013.02.003_bib50","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1097\/00002030-200312050-00008","article-title":"Improved outcomes of HIV-1-infected adults with tuberculosis in the era of highly active antiretroviral therapy","volume":"17","author":"Hung","year":"2003","journal-title":"AIDS"},{"issue":"8","key":"10.1016\/j.ccm.2013.02.003_bib51","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa0905848","article-title":"Timing of initiation of antiretroviral drugs during tuberculosis therapy","volume":"362","author":"Abdool Karim","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.ccm.2013.02.003_bib52","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1056\/NEJMoa1014181","article-title":"Integration of antiretroviral therapy with tuberculosis treatment","volume":"365","author":"Abdool Karim","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.ccm.2013.02.003_bib53","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJMoa1013911","article-title":"Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis","volume":"365","author":"Blanc","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.ccm.2013.02.003_bib54","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1056\/NEJMoa1013607","article-title":"Timing of antiretroviral therapy for HIV-1 infection and tuberculosis","volume":"365","author":"Havlir","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccm.2013.02.003_bib55","unstructured":"United States Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. 2012. Available at: http:\/\/www.aidsinfo.nih.gov\/contentfiles\/lvguidelines\/adultandadolescentgl.pdf. Accessed December 31, 2012."},{"issue":"11","key":"10.1016\/j.ccm.2013.02.003_bib56","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/cid\/cir230","article-title":"Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)\u2013associated tuberculous meningitis","volume":"52","author":"Torok","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.ccm.2013.02.003_bib57","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1473-3099(10)70026-8","article-title":"Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis","volume":"10","author":"Muller","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"15","key":"10.1016\/j.ccm.2013.02.003_bib58","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1097\/QAD.0b013e32833dfc68","article-title":"Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome","volume":"24","author":"Meintjes","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.ccm.2013.02.003_bib59","unstructured":"CDC TB managing drug interactions in the treatment of HIV-related tuberculosis. 2012. Available at: http:\/\/www.cdc.gov\/tb\/publications\/guidelines\/TB_HIV_Drugs\/default.htm. Accessed December 31, 2012."},{"issue":"5","key":"10.1016\/j.ccm.2013.02.003_bib60","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/jama.300.5.530","article-title":"Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy","volume":"300","author":"Boulle","year":"2008","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.ccm.2013.02.003_bib61","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1086\/599114","article-title":"A\u00a0randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in HIV-infected patients receiving rifampicin: the N2R study","volume":"48","author":"Manosuthi","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"Suppl 3","key":"10.1016\/j.ccm.2013.02.003_bib62","doi-asserted-by":"crossref","first-page":"S223","DOI":"10.1086\/651495","article-title":"HIV infection-related tuberculosis: clinical manifestations and treatment","volume":"50","author":"Sterling","year":"2010","journal-title":"Clin Infect Dis"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523113000427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523113000427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:47:22Z","timestamp":1759452442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523113000427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0272523113000427"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2013.02.003","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human Immunodeficiency Virus\u2013Associated Tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2013.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}